AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimigrand-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

D Earth Pharmaceuticals Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimigrand-M1 Tablet SR

Diabex Duo SR tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; premature discontinuation, without consulting your doctor, can elevate blood sugar, risking kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and how to treat it. Maintain regular meals and carry a quick-acting glucose source (e.g., sugary snacks or juice). Alcohol increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabex Duo SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your physician of any prior heart conditions before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your doctor.

Primary Ingredients of Glimigrand-M1 Tablet SR

There is no text provided to rephrase.

Uses of Glimigrand-M1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimigrand-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimigrand-M1 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Glimigrand-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimigrand-M1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimigrand-M1 Tablet SR with a meal.

How Glimigrand-M1 Tablet SR works:

Glimepiride and Metformin, the active components of Glimigrand-M1 SR tablets, synergistically manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimigrand-M1 Tablet SR and alcohol poses a significant safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimigrand-M1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimigrand-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimigrand-M1 Tablet SR cautiously, potentially requiring a modified dosage. Physician consultation is recommended. Glimigrand-M1 Tablet SR is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimigrand-M1 Tablet SR to individuals with hepatic impairment; dosage modifications may be necessary. Consult a physician. For patients exhibiting mild to moderate liver dysfunction, initiate Glimigrand-M1 Tablet SR therapy with a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Glimigrand-M1 Tablet SR :

Should you forget a dose of Glimigrand-M1 Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimigrand-M1 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimigrand-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimigrand-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimigrand-M1 Tablet SR and seek immediate medical attention.
Glimigrand-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimigrand-M1 SR Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimigrand-M1 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimigrand-M1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimigrand-M1 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimigrand-M1 Tablet SR
74
MRP 90
17% off